Myoventive Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

Myoventive General Information

Description

Provider of next-generation, non-viral RNA-based medicines intended for the treatment of genetic cardiac diseases. The company's targeted RNA modulation in the heart addresses genetic cardiac diseases that existing AAV platforms are unable to treat, enabling clients to access potentially safer, more scalable, and re-dosable genetic therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 600 Gateway Boulevard
  • Suite 202
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Vertical(s)
Corporate Office
  • 600 Gateway Boulevard
  • Suite 202
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myoventive Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jun-2025 Completed Startup
To view Myoventive’s complete valuation and funding history, request access »

Myoventive Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
MRL Ventures Fund Corporate Venture Capital Minority
Perceptive Advisors Venture Capital Minority
venBio Venture Capital Minority
To view Myoventive’s complete investors history, request access »

Myoventive FAQs

  • When was Myoventive founded?

    Myoventive was founded in 2025.

  • Where is Myoventive headquartered?

    Myoventive is headquartered in South San Francisco, CA.

  • What industry is Myoventive in?

    Myoventive’s primary industry is Biotechnology.

  • Is Myoventive a private or public company?

    Myoventive is a Private company.

  • What is Myoventive’s current revenue?

    The current revenue for Myoventive is .

  • Who are Myoventive’s investors?

    Alexandria Venture Investments, MRL Ventures Fund, Perceptive Advisors, and venBio have invested in Myoventive.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process